November 11, 2025
University of Pittsburgh law professor Greer Donley talks to Law360 Healthcare Authority about preemption challenges and mifepristone regulation following the GenBioPro decision at the Fourth Circuit.
October 18, 2024
In a joint amicus brief to the Fourth Circuit, a coalition of 17 states and the District of Columbia has said the abortion drug mifepristone is a part of women's reproductive healthcare, assailing the "needless" limits that states including North Carolina have sought to impose on the drug's access.
August 13, 2024
North Carolina Republican lawmakers want the Fourth Circuit to reinstate restrictions on the abortion drug mifepristone, telling the court the new rules concerning the medication are not preempted by U.S. Food and Drug Administration regulations.